These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 35865822)
1. Evaluation of the Effect of Gene Duplication by Genome Editing on Drug Resistance in Kubota R; Ishino T; Iwanaga S; Shinzawa N Front Cell Infect Microbiol; 2022; 12():915656. PubMed ID: 35865822 [TBL] [Abstract][Full Text] [Related]
2. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513 [TBL] [Abstract][Full Text] [Related]
3. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Witkowski B; Duru V; Khim N; Ross LS; Saintpierre B; Beghain J; Chy S; Kim S; Ke S; Kloeung N; Eam R; Khean C; Ken M; Loch K; Bouillon A; Domergue A; Ma L; Bouchier C; Leang R; Huy R; Nuel G; Barale JC; Legrand E; Ringwald P; Fidock DA; Mercereau-Puijalon O; Ariey F; Ménard D Lancet Infect Dis; 2017 Feb; 17(2):174-183. PubMed ID: 27818097 [TBL] [Abstract][Full Text] [Related]
4. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa? Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646 [TBL] [Abstract][Full Text] [Related]
8. Plasmodium berghei K13 Mutations Mediate Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP mBio; 2020 Nov; 11(6):. PubMed ID: 33173001 [TBL] [Abstract][Full Text] [Related]
9. Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Chavchich M; Gerena L; Peters J; Chen N; Cheng Q; Kyle DE Antimicrob Agents Chemother; 2010 Jun; 54(6):2455-64. PubMed ID: 20350946 [TBL] [Abstract][Full Text] [Related]
10. A single point mutation in the Plasmodium falciparum 3'-5' exonuclease does not alter piperaquine susceptibility. Boonyalai N; Kirativanich K; Thamnurak C; Praditpol C; Vesely BA; Wojnarski M; Griesenbeck JS; Waters NC Malar J; 2022 Apr; 21(1):130. PubMed ID: 35459163 [TBL] [Abstract][Full Text] [Related]
11. Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum. Ansbro MR; Jacob CG; Amato R; Kekre M; Amaratunga C; Sreng S; Suon S; Miotto O; Fairhurst RM; Wellems TE; Kwiatkowski DP Malar J; 2020 May; 19(1):181. PubMed ID: 32404110 [TBL] [Abstract][Full Text] [Related]
12. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border. Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT. Shafik SH; Richards SN; Corry B; Martin RE PLoS Biol; 2022 May; 20(5):e3001616. PubMed ID: 35507548 [TBL] [Abstract][Full Text] [Related]
14. Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5). Gendrot M; Wague Gueye M; Tsombeng Foguim F; Madamet M; Wade KA; Bou Kounta M; Fall M; Diawara S; Benoit N; Lo G; Bercion R; Amalvict R; Mosnier J; Fall B; Briolant S; Diatta B; Pradines B Acta Trop; 2019 Aug; 196():126-134. PubMed ID: 31108084 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine. Loesbanluechai D; Kotanan N; de Cozar C; Kochakarn T; Ansbro MR; Chotivanich K; White NJ; Wilairat P; Lee MCS; Gamo FJ; Sanz LM; Chookajorn T; Kümpornsin K Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():16-22. PubMed ID: 30580023 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of Plasmepsins 2 and 3 Sensitizes Plasmodium falciparum to the Antimalarial Drug Piperaquine. Mukherjee A; Gagnon D; Wirth DF; Richard D Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439977 [TBL] [Abstract][Full Text] [Related]
18. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity. Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510 [TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs. Ng CL; Siciliano G; Lee MC; de Almeida MJ; Corey VC; Bopp SE; Bertuccini L; Wittlin S; Kasdin RG; Le Bihan A; Clozel M; Winzeler EA; Alano P; Fidock DA Mol Microbiol; 2016 Aug; 101(3):381-93. PubMed ID: 27073104 [TBL] [Abstract][Full Text] [Related]
20. Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa. Robert MG; Foguim Tsombeng F; Gendrot M; Mosnier J; Amalvict R; Benoit N; Torrentino-Madamet M; Pradines B; Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]